Logo
x

Search

Subscribe Now

Sage

Sage and Biogen Present P-III (SKYLARK) Study Results of Zuranolone for Postpartum Depression at ECNP 2022

Sage and Biogen Present P-III (SKYLARK) Study Results of Zuranolone for Postpartum Depression at ECNP 2022

  • October 17, 2022
Sage and Biogen Report Results of Zuranolone in P-III (CORAL) Study for the Treatment of Major Depressive Disorder

Sage and Biogen Report Results of Zuranolone in P-III (CORAL) Study for the Treatment of Major Depressive Disorder

  • February 17, 2022
Sage and Biogen Presents Results of Zuranolone in LANDSCAPE Clinical Program for Major Depressive Disorder at ACNP 2021

Sage and Biogen Presents Results of Zuranolone in LANDSCAPE Clinical Program for Major Depressive Disorder at ACNP 2021

  • December 8, 2021
Sage and Biogen Report One-Year Results of Zuranolone in the P-III (SHORELINE) Study for the MDD

Sage and Biogen Report One-Year Results of Zuranolone in the P-III (SHORELINE) Study for the MDD

  • December 1, 2021
PharmaShots Weekly Snapshots (October 04 - 08, 2021)

PharmaShots Weekly Snapshots (October 04 - 08, 2021)

  • October 8, 2021
PharmaShots Weekly Snapshots (June 14 - 18, 2021)

PharmaShots Weekly Snapshots (June 14 - 18, 2021)

  • June 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.